Cargando…

Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton

Platelet shape change induced by ADP is relatively independent of external pH over the range 6-7. If the chloride ion in the buffer is replaced by weak acids, however, shape change is rapidly and reversibly inhibited as a function of lowered pH (92% at pH 6.0). This inhibition is correlated with low...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2114642/
https://www.ncbi.nlm.nih.gov/pubmed/3667696
_version_ 1782140467826130944
collection PubMed
description Platelet shape change induced by ADP is relatively independent of external pH over the range 6-7. If the chloride ion in the buffer is replaced by weak acids, however, shape change is rapidly and reversibly inhibited as a function of lowered pH (92% at pH 6.0). This inhibition is correlated with lowered internal pH caused by the weak acids, as measured by the 5,5-dimethyloxazolidine 2,4-dione technique. Shape change was 50% inhibited at internal pH 6.4 when 50 mM NaCl was replaced by propionate (PR). When platelets were stimulated with ADP 10- 20 s after addition of PR to a final pH of 6 (PR6), both myosin light chain (MLC) phosphorylation and myosin and actin association with the cytoskeleton were reduced in correlation with the inhibition of shape change. But when ADP was added 30 s after PR6, the MLC phosphorylation was essentially the same in PR or in chloride, although shape change and myosin and actin association with the cytoskeleton remained inhibited. This was shown to be due mainly to endogenous phosphorylation of MLC. On return to neutral pH, platelets in PR immediately changed shape and myosin and actin became associated with the cytoskeleton. Two-dimensional tryptic peptides of MLC showed two major spots after PR6 treatment, indicating that both the MLC kinase site and the protein kinase C sites were phosphorylated. The results show that increased internal pH is not required for shape change, although it may affect the rate. In PR6, as after phorbol esters, MLC phosphorylation can be uncoupled from shape change. The association of myosin and actin with the cytoskeleton is closely correlated with shape change, suggesting that shape change requires the active interaction of these contractile proteins.
format Text
id pubmed-2114642
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21146422008-05-01 Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton J Cell Biol Articles Platelet shape change induced by ADP is relatively independent of external pH over the range 6-7. If the chloride ion in the buffer is replaced by weak acids, however, shape change is rapidly and reversibly inhibited as a function of lowered pH (92% at pH 6.0). This inhibition is correlated with lowered internal pH caused by the weak acids, as measured by the 5,5-dimethyloxazolidine 2,4-dione technique. Shape change was 50% inhibited at internal pH 6.4 when 50 mM NaCl was replaced by propionate (PR). When platelets were stimulated with ADP 10- 20 s after addition of PR to a final pH of 6 (PR6), both myosin light chain (MLC) phosphorylation and myosin and actin association with the cytoskeleton were reduced in correlation with the inhibition of shape change. But when ADP was added 30 s after PR6, the MLC phosphorylation was essentially the same in PR or in chloride, although shape change and myosin and actin association with the cytoskeleton remained inhibited. This was shown to be due mainly to endogenous phosphorylation of MLC. On return to neutral pH, platelets in PR immediately changed shape and myosin and actin became associated with the cytoskeleton. Two-dimensional tryptic peptides of MLC showed two major spots after PR6 treatment, indicating that both the MLC kinase site and the protein kinase C sites were phosphorylated. The results show that increased internal pH is not required for shape change, although it may affect the rate. In PR6, as after phorbol esters, MLC phosphorylation can be uncoupled from shape change. The association of myosin and actin with the cytoskeleton is closely correlated with shape change, suggesting that shape change requires the active interaction of these contractile proteins. The Rockefeller University Press 1987-10-01 /pmc/articles/PMC2114642/ /pubmed/3667696 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
title Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
title_full Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
title_fullStr Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
title_full_unstemmed Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
title_short Lowering pH in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
title_sort lowering ph in blood platelets dissociates myosin phosphorylation from shape change and myosin association with the cytoskeleton
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2114642/
https://www.ncbi.nlm.nih.gov/pubmed/3667696